ASX:RHY Rhythm Biosciences (RHY) Stock Price, News & Analysis → Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (From Weiss Ratings) (Ad) Free RHY Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Rhythm Biosciences alerts: Email Address Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… About Rhythm Biosciences Stock (ASX:RHY)Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.Read More Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… RHY Stock News HeadlinesJune 1 at 6:50 AM | americanbankingnews.comInsider Buying: Rhythm Biosciences Limited (ASX:RHY) Insider Purchases A$37,146.56 in StockMay 29, 2024 | finanznachrichten.deNeurocrine Biosciences, Inc.: Neurocrine Biosciences Announces CEO Succession PlanMay 8, 2024 | uk.finance.yahoo.comQ1 2024 Pulse Biosciences Inc Earnings CallMay 1, 2024 | finanznachrichten.deNeurocrine Biosciences, Inc.: Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA SPRINKLE (valbenazine) CapsulesApril 17, 2024 | msn.comWill and Jada Pinkett Smith make appearance at Coachella together to cheer on daughter WillowApril 14, 2024 | msn.comDr Boreham’s Crucible: Is Breastest the bestest breast test? Bcal’s close to finding outApril 1, 2024 | msn.comPulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comOne Rhythm Biosciences Insider Raised Their Stake In The Previous YearFebruary 1, 2024 | yahoo.comListen to an Exclusive Track From The Underdoggs by Joseph ShirleyJanuary 25, 2024 | yahoo.comIconic Phoenix music club turns to GoFundMe to survive: 'We could use the community's help'December 13, 2023 | finance.yahoo.comRhythm Biosciences Limited (RHY.AX)November 30, 2023 | benzinga.comCatheter Precision Inc. (NYSE American: VTAK) Spotlighted in "Cardiac Rhythm News" for Revolutionary Advances in Cardiac Treatment"November 23, 2023 | msn.comASX Health Stocks: Rhythm Bio says new research in lung cancer is warranted after this findingNovember 18, 2023 | afr.comRhythm Biosciences LimitedMay 12, 2022 | fool.com.auRhythm Biosciences share price lifts 5% on TGA newsMay 3, 2022 | investing.comRhythm Biosciences Ltd (RHY)See More Headlines Receive RHY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rhythm Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:RHY CUSIPN/A CIKN/A Webwww.rhythmbio.com Phone61 3 8256 2880FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,630,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-171.97% Return on Assets-91.64% Debt Debt-to-Equity Ratio3.13 Current Ratio2.05 Quick Ratio8.24 Sales & Book Value Annual Sales$2.07 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares248,600,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta2.70 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Otto Leslie-Steven Buttula AIMM (Age 60)B.Ec., Grad. Dip., MAICD, Executive Chairman Comp: $182.32kMr. Guy CarisbrookeFinancial ControllerMs. Andrea Steele LLB B Com LLMGeneral Counsel & Joint Company SecretaryMs. Elena DeakChief Commercial OfficerMr. James Stephen Barrie CPAJoint Company SecretaryKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersOtto ButtulaBought 546,273 shares on 5/27/2024Total: $37,146.56 ($0.07/share)Trevor LockettSold 193,650 sharesTotal: $19,365.00 ($0.10/share)Trevor LockettBought 1,125,000 shares on 8/8/2023Total: $225,000.00 ($0.20/share) This page (ASX:RHY) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden Nomination CANCELED?The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Biosciences Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
